AAAAAA
Results: 26-50/57
Authors:
WEISS GR
MARGOLIN KA
SZNOL M
ATKINS MB
OLEKSOWICZ L
ISAACS R
SOSMAN JA
DOROSHOW JH
TREHU EG
DUTCHER JP
FISHER RI
Citation: Gr. Weiss et al., A PHASE-II STUDY OF THE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-6 FOR METASTATIC RENAL-CELL CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 18(1), 1995, pp. 52-56
Authors:
SOSMAN JA
KEFER C
FISHER RI
JACOBS CD
PUMFERY P
ELLIS TM
Citation: Ja. Sosman et al., A PHASE IA IB TRIAL OF ANTI-CD3 MURINE MONOCLONAL-ANTIBODY PLUS LOW-DOSE CONTINUOUS-INFUSION INTERLEUKIN-2 IN ADVANCED CANCER-PATIENTS/, Journal of immunotherapy with emphasis on tumor immunology, 17(3), 1995, pp. 171-180
Authors:
FYFE G
FISHER RI
ROSENBERG SA
SZNOL M
PARKINSON DR
LOUIE AC
Citation: G. Fyfe et al., RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY, Journal of clinical oncology, 13(3), 1995, pp. 688-696
Authors:
ALZONA M
JACK HM
FISHER RI
ELLIS TM
Citation: M. Alzona et al., IL-12 ACTIVATES IFN-GAMMA PRODUCTION THROUGH THE PREFERENTIAL ACTIVATION OF CD30(-CELLS() T), The Journal of immunology, 154(1), 1995, pp. 9-16
Authors:
SWINNEN LJ
MULLEN GM
CARR TJ
COSTANZO MR
FISHER RI
Citation: Lj. Swinnen et al., AGGRESSIVE TREATMENT FOR POSTCARDIAC TRANSPLANT LYMPHOPROLIFERATION, Blood, 86(9), 1995, pp. 3333-3340
Authors:
WINTER JN
ANDERSEN J
REED JC
KRAJEWSKY S
VARIAKOJIS D
FISHER RI
GORDON LI
OKEN MM
BAUER KD
DOMER P
Citation: Jn. Winter et al., BCL-2 EXPRESSION CORRELATES WITH LOWER PROLIFERATIVE ACTIVITY IN NON-HODGKINS-LYMPHOMA (NHL), AN ECOG STUDY, Blood, 86(10), 1995, pp. 1351-1351
Authors:
FISHER RI
DAHLBERG S
NATHWANI BN
BANKS PM
MILLER TP
GROGAN TM
Citation: Ri. Fisher et al., A CLINICAL ANALYSIS OF 2 INDOLENT LYMPHOMA ENTITIES - MANTLE CELL LYMPHOMA AND MARGINAL ZONE LYMPHOMA (INCLUDING THE MUCOSA-ASSOCIATED LYMPHOID-TISSUE AND MONOCYTOID B-CELL SUBCATEGORIES) - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Blood, 85(4), 1995, pp. 1075-1082
Authors:
SPARANO JA
FISHER RI
WEISS GR
MARGOLIN K
ARONSON FR
HAWKINS MJ
ATKINS MB
DUTCHER JP
GAYNOR ER
BOLDT DH
DOROSHOW JH
ERNEST ML
SZNOL M
MIER JW
Citation: Ja. Sparano et al., PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
Authors:
MARGOLIN K
ARONSON FR
SZNOL M
ATKINS MB
GUCALP R
FISHER RI
SUNDERLAND M
DOROSHOW JH
ERNEST ML
MIER JW
DUTCHER JP
GAYNOR ER
WEISS GR
Citation: K. Margolin et al., PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 147-153
Authors:
HAWKINS MJ
ATKINS MB
DUTCHER JP
FISHER RI
WEISS GR
MARGOLIN KA
RAYNER AA
SZNOL M
PARKINSON DR
PAIETTA E
GAYNOR ER
BOLDT DH
DOROSHOW JH
ARONSON FR
Citation: Mj. Hawkins et al., A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 74-78
Authors:
SOSMAN JA
FISHER SG
KEFER C
FISHER RI
ELLIS TM
Citation: Ja. Sosman et al., A PHASE-I TRIAL OF CONTINUOUS-INFUSION INTERLEUKIN-4 (IL-4) ALONE ANDFOLLOWING INTERLEUKIN-2 (IL-2) IN CANCER-PATIENTS, Annals of oncology, 5(5), 1994, pp. 447-452
Authors:
FISHER RI
GAYNOR ER
DAHLBERG S
OKEN MM
GROGAN TM
MIZE EM
GLICK JH
COLTMAN CA
MILLER TP
Citation: Ri. Fisher et al., A PHASE-III COMPARISON OF CHOP VS M-BACOD VS PROMACE-CYTABOM VS MACOP-B IN PATIENTS WITH INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF SWOG-8516 (INTERGROUP 0067), THE NATIONAL HIGH-PRIORITY LYMPHOMA STUDY, Annals of oncology, 5, 1994, pp. 190000091-190000095
Authors:
ATKINS MB
OBOYLE KR
SOSMAN JA
WEISS GR
MARGOLIN KA
ERNEST ML
KAPPLER K
MIER JW
SPARANO JA
FISHER RI
ECKARDT JR
PEREIRA C
ARONSON FR
Citation: Mb. Atkins et al., MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA, Journal of clinical oncology, 12(8), 1994, pp. 1553-1560
Authors:
HAMM J
SCHILLER JH
CUFFIE C
OKEN M
FISHER RI
SHEPHERD F
KAISER G
Citation: J. Hamm et al., DOSE-RANGING STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN SMALL-CELL LUNG-CARCINOMA, Journal of clinical oncology, 12(12), 1994, pp. 2667-2676
Authors:
LONGO DL
DUFFEY PL
JAFFE ES
RAFFELD M
HUBBARD SM
FISHER RI
WITTES RE
DEVITA VT
YOUNG RC
Citation: Dl. Longo et al., DIFFUSE SMALL NONCLEAVED-CELL, NON-BURKITTS LYMPHOMA IN ADULTS - A HIGH-GRADE LYMPHOMA RESPONSIVE TO PROMACE-BASED COMBINATION CHEMOTHERAPY, Journal of clinical oncology, 12(10), 1994, pp. 2153-2159
Authors:
SAEZ R
DAHLBERG S
APPELBAUM FR
HARTSOCK RJ
LEMAISTRE F
COLTMAN CA
FISHER RI
Citation: R. Saez et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADULTS WITH NON-HODGKINS-LYMPHOMA - A SOUTHWEST-ONCOLOGY-GROUP, Hematological oncology, 12(2), 1994, pp. 75-85
Authors:
ALZONA M
JACK HM
FISHER RI
ELLIS TM
Citation: M. Alzona et al., CD30 DEFINES A SUBSET OF ACTIVATED HUMAN T-CELLS THAT PRODUCE IFN-GAMMA AND IL-5 AND EXHIBIT ENHANCED B-CELL HELPER ACTIVITY, The Journal of immunology, 153(7), 1994, pp. 2861-2867
Authors:
FISHER RI
Citation: Ri. Fisher, TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS - LESSONS FROM THE PAST 10 YEARS, Cancer, 74(9), 1994, pp. 2657-2661
Authors:
MILLER TP
GROGAN TM
DAHLBERG S
SPIER CM
BRAZIEL RM
BANKS PM
FOUCAR K
KJELDSBERG CR
LEVY N
NATHWANI BN
SCHNITZER B
TUBBS RR
GAYNOR ER
FISHER RI
Citation: Tp. Miller et al., PROGNOSTIC-SIGNIFICANCE OF THE KI-67 ASSOCIATED PROLIFERATIVE ANTIGENIN AGGRESSIVE NON-HODGKINS-LYMPHOMAS - A PROSPECTIVE SOUTHWEST-ONCOLOGY-GROUP TRIAL, Blood, 83(6), 1994, pp. 1460-1466
Authors:
NAND S
SOSMAN J
GODWIN JE
FISHER RI
Citation: S. Nand et al., A PHASE I II STUDY OF SEQUENTIAL INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN MYELODYSPLASTIC SYNDROMES/, Blood, 83(2), 1994, pp. 357-360
Authors:
FABIAN CJ
MANSFIELD CM
DAHLBERG S
JONES SE
MILLER TP
VANSLYCK E
GROZEA PN
MORRISON FS
COLTMAN CA
FISHER RI
Citation: Cj. Fabian et al., LOW-DOSE INVOLVED FIELD RADIATION AFTER CHEMOTHERAPY IN ADVANCED HODGKIN DISEASE - A SOUTHWEST-ONCOLOGY-GROUP RANDOMIZED STUDY, Annals of internal medicine, 120(11), 1994, pp. 903-912
Authors:
SOSMAN JA
WEISS GR
MARGOLIN KA
ARONSON FR
SZNOL M
ATKINS MB
OBOYLE K
FISHER RI
BOLDT DH
DOROSHOW J
ERNEST ML
FISHER SG
MIER J
VACHINO G
CALIENDO G
Citation: Ja. Sosman et al., PHASE-IB CLINICAL-TRIAL OF ANTI-CD3 FOLLOWED BY HIGH-DOSE BOLUS INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND ADVANCED RENAL-CELL CARCINOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS, Journal of clinical oncology, 11(8), 1993, pp. 1496-1505
Authors:
SPARANO JA
FISHER RI
SUNDERLAND M
MARGOLIN K
ERNEST ML
SZNOL M
ATKINS MB
DUTCHER JP
MICETICH KC
WEISS GR
DOROSHOW JH
ARONSON FR
RUBINSTEIN LV
MIER JW
Citation: Ja. Sparano et al., RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA, Journal of clinical oncology, 11(10), 1993, pp. 1969-1977
Authors:
FISHER RI
Citation: Ri. Fisher, TREATMENT OF ADVANCED NON-HODGKINS-LYMPHOMAS, Journal of cellular biochemistry, 1993, pp. 258-258
Authors:
POPLIN E
FLEMING T
MACDONALD JS
EISENBERG P
FISHER RI
CONRAD ME
Citation: E. Poplin et al., AMONAFIDE TREATMENT OF REFRACTORY ESOPHAGEAL CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 11(1), 1993, pp. 47-51